Anticoagulation dosage strategy therapy, length of stay, and all-cause mortality in critically ill COVID-19 patients admitted to the intensive care unit

Few studies examined several anticoagulation (AC) dosage strategy therapies for various outcomes among coronavirus disease-2019 (COVID-19) patients. However, this AC dosage strategy therapy has not been investigated to assess the length of stay (LOS) and all-cause mortality among critically ill COVI...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicine (Baltimore) 2024-01, Vol.103 (1), p.e36854-e36854
Hauptverfasser:	Vennu, Vishal, Alshammary, Amal F
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - therapeutic use COVID-19 Critical Illness - therapy Heparin - therapeutic use Humans Intensive Care Units Length of Stay Observational Study
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!